Back
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND Vs. Agios Pharmaceuticals Industry Stock Comparison
Sell
48
EVT
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND
Last Price:
24.63
Seasonality Move:
0.59%
Sell
1
AGIO
Agios Pharmaceuticals
Last Price:
38.94
Seasonality Move:
12.89%
Sell
48
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND (EVT)
is a Sell
Is EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND a Buy, Sell or Hold?
- The current EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND [EVT] share price is $24.77. The Score for EVT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- EVT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $38.17. The Score for AGIO is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
EVT Stock Price Chart
What is EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND's stock price today?
-
The EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND share price today is $24.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVT is experiencing slight selling pressure.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $38.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing selling pressure, which indicates risk of future bearish movement.
EVT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 40.1 | Sell |
Chaikin Money Flow: | -39829 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.02 - 25.46) | Sell |
Bollinger Bands (100): | (23.83 - 25.03) | Buy |
AGIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.34 | Sell |
Relative Strength Index (14 RSI): | 26.34 | Sell |
Chaikin Money Flow: | -1550643 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.73 - 60.93) | Sell |
Bollinger Bands (100): | (42.01 - 53.19) | Sell |
EVT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.19 | Sell |
20-day SMA: | 25.26 | Sell |
50-day SMA: | 24.85 | Sell |
200-day SMA: | 23.83 | Buy |
8-day EMA: | 25.11 | Sell |
20-day EMA: | 25.15 | Sell |
50-day EMA: | 24.89 | Sell |
200-day EMA: | 23.93 | Buy |
AGIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.89 | Sell |
20-day SMA: | 54.55 | Sell |
50-day SMA: | 49.66 | Sell |
200-day SMA: | 41.9 | Sell |
8-day EMA: | 48.9 | Sell |
20-day EMA: | 52.35 | Sell |
50-day EMA: | 50.92 | Sell |
200-day EMA: | 42.82 | Sell |
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND Earnings Growth & EVT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.46 per share, and a decrease next year of $16.90 per share.
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Agios Pharmaceuticals Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |